Showing results (201-210 of 282) with videos related to
Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfateM Markman, R D'Acquisto, N Iannotti, et al.Life Sciences|December 22, 1986
Sarcoid and cytotoxic lung antibodiesN Ende, J N Grizzanti, E V Orsi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|December 6, 2005
Smoking and tuberculosis: the epidemiological association and immunopathogenesisP D O Davies, W W Yew, D Ganguly, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.Cancer|February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancerJ Crown, T Hakes, B Reichman, et al.Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.Gynecologic Oncology|July 1, 1993
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Pageof 29